The Boswellia species (Burseraceae), which are trees native to Ethiopia, Somalia, India, and the Arabic peninsula, produce a gum resin that is known as olibanum (frankincense). The resin of B. carteri and B. serrata has been used for the treatment of rheumatoid arthritis and other inflammatory diseases in the traditional medicine in many countries.
Cancer Chemopreventive Effects and Cytotoxic Activities of the Triterpene Acids from the Resin of Boswellia carteri
as estimated based on the amount of the isolated compound), acetyl b-boswellic acid (2; 5.56%), acetyl 11-keto-bboswellic acid (4; 4.60%), 9,11-dehydro-b-boswellic acid (6; 0.10%), acetyl 9,11-dehydro-b-boswellic acid (7; 0.39%), aboswellic acid (8; 0.31%), acetyl a-boswellic acid (9; 1.26%), lupeolic acid (10; 0.29%), acetyl lupeolic acid (11; 0.51%), a-elemolic acid (12; 0.49%), elemonic acid (13; 2.93%), incensole (17; 1.90%), incensole acetate (18; 1.32%). The EtOAc-soluble fraction was subjected to column chromatography on a silica gel followed by preparative reversed-phase HPLC which gave compounds 1 (ca. 2.41% of the EtOAc-soluble fraction), 2 (0.37%), 11-keto-b-boswellic acid (3; 1.11%), 4 (4.18%), acetyl 11a-methoxy-b-boswellic acid (5; 0.32%), 8 (4.93%), 10 (0.36%), 13 (1.06%), 3a-hydroxytirucalla-7,24-dien-21-oic acid (14; 1.18%), 3a-hydroxytirucalla-8,24-dien-21-oic acid (16; 0.47%), and 17 (0.36%). 3b-Acetoxytirucalla-7,24-dien-21-oic acid (15) was obtained from compound 14 by acetylation.
11) The chemical structures of compounds 1-18 were shown in Chart 1.
In Vitro EBV-EA Activation Experiment The EBV genome-carrying lymphoblastoid cells, Raji cells, derived from Burkitt's lymphoma, were cultured in RPMI-1640 medium (Sigma, St. Louis). The Raji cells were incubated for 48 h at 37°C in a medium containing n-butanoic acid (4 mM), TPA (32 pM), and various amounts of each test compound. Smears were made from the cell suspension, and the EBV-EA-inducing cells were stained by means of an indirect immunofluorescence technique. Details of this in vitro assay on EBV-EA induction have been reported previously.
12)
In Vitro NOR 1 Inhibition Experiment 13) Chang liver cells (normal human hepatic cells; 5ϫ10 5 /ml), derived from human liver in an MEM Eagle medium, were cultured three days before treatment. NOR 1 was added into culture dish and incubated for 1 h under a CO 2 incubator as a control. For the screening assay, test samples were added to the culture dish 1 min before of NOR 1 treatment. Transformed cells were observed under light microscopy (ϫ100). All observed cells counted for more than 250. The inhibitory ratio was then calculated, as follows: and vehicle were applied for 48 h. After addition of 0.5% MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] solution as a 1/10 volume of medium in the well, incubation was continued for a further 3 h at 37°C/5% CO 2 . An equal volume of stop solution (0.04 N HCl in 2-propanol) to that of the culture medium was then added to each well and the absorbance at 570 nm (peak) and 655 nm (bottom) was measured after thorough pipetting to disperse the generated blue formazan. Data were analyzed by one-way analysis of variance (ANOVA) followed by the Bonferroni's test for multiple comparisons among different groups. A difference of pϽ0.05 was considered significant.
RESULTS AND DISCUSSION
The MeOH extract of the resin of B. carteri, and the nhexane-, EtOAc-, n-BuOH-, and H 2 O-soluble fractions obtained therefrom were examined against TPA (32 pmol)-induced EBV-EA activation in Raji cells. As shown in Table 1 , the n-hexane-and EtOAc-soluble fractions, both of which constituted major portions of the MeOH extract, exhibited potent inhibitory activities in this assay system (38-40% in- hibition of EBV-EA activation at a dose of 10 mg/ml). The nhexane-and EtOAc-soluble fractions were found to contain triterpene acids abundantly, and no substantial difference in the composition of triterpene acids was observed between the two fractions. Fifteen triterpene acids, viz., seven of the bboswellic acids (ursane-type) (1-7), two of the a-boswellic acids (oleanane-type) (8, 9), two of the lupeolic acids (lupane-type) (10, 11), and four of the tirucallane-type (12-14, 16), together with two diterpens (incensoles) (17, 18), were isolated and identified.
11)
The inhibitory effects on EBV-EA activation induced by TPA was examined as a preliminary evaluation of the potential antitumor-promoting activities 15, 16) for the seventeen compounds, 1-14 and 16-18, along with 15 (the acetyl derivative of 14) . The results are shown in Table 2 , together with comparable data for b-carotene, a vitamin A precursor that has been intensively studied in cancer chemoprevention by using in vitro, in vivo, and epidemiological test systems. 17) Of the tested compounds, seven compounds, 2, 10, 11, and 13-16, showed potent inhibitory effects with IC 50 values of 339-397 mol ratio/32 pmol TPA, while preserving the high viability of Raji cells, which were equivalent to or more potent than b-carotene (IC 50 397 mol ratio/32 pmol TPA). Since the inhibitory effects against EBV-EA induction have been demonstrated to correlate with those against tumor promotion in vivo, 12) these compounds may be potential antitumorpromoters. The other eleven compounds, 1, 3-9, 12, 17, and 18, showed moderate inhibitory effects on EBV-EA activation (IC 50 431-499 mol ratio/32 pmol TPA).
Using an in vitro screening model for NO scavenging, 13) the inhibitory effects of compounds 1-18 were evaluated for their scavenging activity against NO generation by NOR 1 in a cultured cell system. The inhibitory effects on activation of NOR 1 has been demonstrated to closely parallel those against tumor initiation in vivo. 18) Table 2 shows the inhibitory ratios (I.R.) of the 18 compounds and two reference compounds, glycyrrhizin, one of the most studied natural triterpenoids from point of view of its chemopreventive potency, 15) and the synthetic NO scavenger, carboxy-PTIO, on NOR 1 action. Among the isolates tested, five compounds, 7, and 13-16, exhibited potent inhibitory effects (I.R. 1.9-2.2) that were almost equivalent to the value for glyzyrrhizin (I.R. 2.2). It is noteworthy that four (13-16) among the five compounds exhibited potent inhibitory effects also on EBV-EA induction, as mentioned above. NO is known to be involved in several potential toxic mechanisms and is a mutagen and can cause mutations in both microorganisms and mammalian cells. 19, 20) The cytotoxic activities of compounds 1-18 and cisplatin, which is one of the most effective and widely used chemotherapeutic drugs employed in the treatment of human cancers, against three human neuroblastoma cell lines, IMR-32, NB-39, and SK-N-SH, are shown in Table 2 . Fifteen compounds, 1-7, 9-11, 13-15, 17, and 18, exhibited potent cytotoxic activities with IC 50 values of 4.1-82.4 mM against all of the three cell lines tested. Among these compounds, compounds 3, 5, 9, and 14 showed almost comparable with or higher activity (IC 50 13.4-28.2 mM) than cisplatin (26.0 mM) against NB-39. In addition, compounds 9 (IC 50 24.0 mM), 11 (4.7 mM), and 15 (22.2 mM) exhibited almost comparable with or higher activity than cisplatin (23.0 mM) against SK-N-SH. It appears that acetylation of the hydroxyl group at C-3a gives rise to higher activity for aboswellic acid (9/8) on all of the three cell lines tested, and for lupeolic acid (11/10) and 3a-hydroxytirucalla-7,24-dien-21-oic acid (15/14) on IMR-32 and SK-N-SH.
From the results of in vitro EBV-EA induction and in vitro NOR 1 inhibition, it may be suggested that triterpene acid constituents of the MeOH extract of B. carteri resin may be useful as agents that inhibit chemical carcinogenesis. In addition, the potent cytotoxic activity of triterpene acids found in the assays with neuroblastoma cell lines in this study might be further investigated to clarify whether or not they are potentially useful in the therapy of a particular type of neoplasia as neuroblatoma.
